Contact Us
Environment
News
Careers
Home
About Us
Our Products
Manufacturing
Sales
NHS
Fish oil supplements may help fight against Type 2 diabetes
|
Vortioxetine, a new multimodal agent in development for the treatment of major depression
|
Research offers promising new approach to treatment of lung cancer
|
Global recommendations on child medicine
|
Breakup of physician, drug company relationship could improve health care, cut cost
|
Nanotechnology could help fight diabetes
|
AstraZeneca issues update on accelerated oncology pipeline
|
First prospective trial shows molecular profiling timely for tailoring therapy
|
GSK and Save the Children form unique partnership to save the lives of one million children
|
Breakthrough in how pancreatic cancer cells ingest nutrients points to new drug target
|
Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis
|
Amgen and Zhejiang Beta Pharma announce planned joint venture in China
|
Boehringer Ingelheim joins Structural Genomics Consortium
|
Real-world data at ARVO highlight transformational outcomes seen with Lucentis®
|
New class of drug targets skin cancer
|
Bristol-Myers Squibb and Pfizer announce publication of ARISTOTLE subanalysis in Circulation
|
Funding boost for GSK's open innovation research into diseases affecting the developing world
|
Study opens new prospects for developing new targeted therapies for breast cancer
|
Experts discuss ways to embed patient voices and values in clinical research
|
Lundbeck is well on track to deliver on guidance for 2013
|
.jpg)
